Holmium Laser Ablation of the Prostate Versus Photoselective Vaporization of Prostate 60 cc or Less: Short-Term Results of a Prospective Randomized Trial

被引:21
作者
Elzayat, Ehab A. [1 ,2 ]
Al-Mandil, Majid S. [1 ]
Khalaf, Ismail [2 ]
Elhilali, Mostafa M. [1 ]
机构
[1] McGill Univ, Div Urol, Montreal, PQ, Canada
[2] Al Azhar Univ, Dept Urol, Cairo, Egypt
关键词
lasers; solid-state; transurethral resection of prostate; ablation techniques; prostatic hyperplasia; prostatectomy; TRANSURETHRAL RESECTION; HYPERPLASIA; OUTCOMES; THERAPY; IMPACT; MEN; KTP;
D O I
10.1016/j.juro.2009.02.117
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We report on the first randomized trial to our knowledge comparing holmium laser ablation and photoselective vaporization of the prostate in patients with a small to moderate size prostate. Materials and Methods: Between March 2005 and April 2007, 109 patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and prostate size 60 cc or smaller were randomized to photoselective vaporization of the prostate (52) or holmium laser ablation of the prostate (57). All patients were evaluated by preoperative and postoperative International Prostate Symptom Score, peak flow rate and post-void residual urine volume, measurement of prostate specific antigen and transrectal ultrasound prostate volume. Followup evaluations were performed during visits at 1, 3, 6 and 12 months. Results: Mean +/- SD preoperative prostate volume was 33.1 +/- 14.5 and 37.3 +/- 13.6 cc in the holmium laser ablation group and the photoselective vaporization group, respectively. Holmium laser ablation of the prostate required more operating time than photoselective vaporization (69.8 vs 55.5 minutes, p = 0.008). In the holmium laser ablation group the International Prostate Symptom Score improved from 20 +/- 6.8 to 6.2 +/- 3.9 and peak urinary flow rate increased from 6.7 +/- 3.9 to 17.2 +/- 8 ml per second. In the photoselective vaporization group the International Prostate Symptom Score improved from 18.4 +/- 6.6 to 8.2 +/- 6.2 and peak urinary flow rate increased from 6.4 +/- 3.9 to 18.4 +/- 8.4 ml per second. Urethral stricture rates were 1.7% vs 5.7%, bladder neck contractures were 3.5% vs 7.7% and revaporization rates were 3.5% vs 1.9% in the holmium laser ablation and photoselective vaporization groups, respectively. Conclusions: Holmium laser ablation and photoselective vaporization of the prostate are safe and effective in patients with benign prostatic hyperplasia with a small to moderate size prostate. Both procedures are easy to learn but holmium laser ablation of the prostate requires a longer operating time.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 20 条
  • [11] High power potassium-titanyl-phosphate laser vaporization prostatectomy
    Malek, RS
    Kuntzman, RS
    Barrett, DM
    [J]. JOURNAL OF UROLOGY, 2000, 163 (06) : 1730 - 1733
  • [12] Randomized comparison of transurethral electroresection and Holmium:YAG laser vaporization for symptomatic benign prostatic hyperplasia
    Mottet, N
    Anidjar, M
    Bourdon, O
    Louis, JF
    Teillac, P
    Costa, P
    Le Duc, A
    [J]. JOURNAL OF ENDOUROLOGY, 1999, 13 (02) : 127 - 130
  • [13] Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation
    Ruszat, Robin
    Wyler, Stephen
    Forster, Thomas
    Reich, Oliver
    Stief, Christian G.
    Gasser, Thomas C.
    Sulser, Tullio
    Bachmann, Alexander
    [J]. EUROPEAN UROLOGY, 2007, 51 (04) : 1031 - 1041
  • [14] Photoselective vaporization of the prostate: Subgroup analysis of men with refractory urinary retention
    Ruszat, Robin
    Wyler, Stephen
    Seifert, Hans-Helge
    Reich, Oliver
    Forster, Thomas
    Sulser, Tullio
    Bachmann, Alexander
    [J]. EUROPEAN UROLOGY, 2006, 50 (05) : 1040 - 1049
  • [15] High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates
    Sandhu, JS
    Ng, C
    Vanderbrink, BA
    Egan, C
    Kaplan, SA
    Te, AE
    [J]. UROLOGY, 2004, 64 (06) : 1155 - 1159
  • [16] Lasers in the treatment of benign prostatic hyperplasia: an update
    Tan, AH
    Gilling, PJ
    [J]. CURRENT OPINION IN UROLOGY, 2005, 15 (01) : 55 - 58
  • [17] Long-term results of high-power holmium laser vaporization (ablation) of the prostate
    Tan, AHH
    Gilling, PJ
    Kennett, KM
    Fletcher, H
    Fraundorfer, MR
    [J]. BJU INTERNATIONAL, 2003, 92 (07) : 707 - 709
  • [18] Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial
    Te, AE
    Malloy, TR
    Stein, BS
    Ulchaker, JC
    Nseyo, UO
    Hai, MA
    Malek, RS
    [J]. JOURNAL OF UROLOGY, 2004, 172 (04) : 1404 - 1408
  • [19] Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate
    Volkan, T
    Ihsan, TA
    Yilmaz, O
    Emin, O
    Selcuk, S
    Koray, K
    Bedi, O
    [J]. EUROPEAN UROLOGY, 2005, 48 (04) : 608 - 613
  • [20] Practice patterns in benign prostatic hyperplasia surgical therapy: The dramatic increase in minimally invasive technologies
    Yu, Xinhua
    Elliott, Sean P.
    Wilt, Timothy J.
    McBean, A. Marshall
    [J]. JOURNAL OF UROLOGY, 2008, 180 (01) : 241 - 245